רווח תפעולי לפני פחת: 60 Degrees Pharmaceuticals (SXTP)
A neutral geopolitical backdrop and the humanitarian status of 60 Degrees Pharmaceuticals (SXTP) create a foundation for growth, supported by the integration of ESG standards and bioethics into drug development. The EBITDA level confirms the trend, where 0.00 records a new benchmark. Financial stability is based on government procurement and the sale of tropical infection treatments to military personnel and travelers.
%20%D7%A8%D7%95%D7%95%D7%97%20%D7%AA%D7%A4%D7%A2%D7%95%D7%9C%D7%99%20EBITDA&width=1200&height=400&colorIndex=0&v=mwczyyub.rjb-7czcsu8&start=20220704&end=20261112&filename=GURU_Markets_-_SXTP_-_60-Degrees-Pharmaceuticals_-_Operating-profit-EBITDA "60 Degrees Pharmaceuticals, Inc. - רווח לפני ניכוי ריבית, מסים, בלאי ופחת SXTP (תקופה 23.11.2025 - 12.11.2026) | 👁️GURU.Markets👁️")
60 Degrees Pharmaceuticals, Inc. - פילוחים אנליטיים ומדדי מפתח (SXTP)
By developing partnerships with global organizations fighting tropical infections and malaria, 60 Degrees Pharmaceuticals (SXTP) is directly dependent on the dynamics of current inflows. This operational financial result captures the daily liquidity inflow from sales, allowing investors to identify abnormal profit spikes that often signal an upcoming cooling of demand and a correction in the asset's market value.
